← Back to directory

Vera Hirsh

Researcher Next ID · RN-014346

Researcher · Medicine

Taipei Veterans General Hospital

, Taiwan

Not currently recruitingFunding unknown
Works count
267
Citation count
33,156
H-index
61
i10-index
135

Research interests

Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Lung Cancer Diagnosis and Treatment
Colorectal Cancer Treatments and Studies
Bone health and treatments

Publications

  • Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

    The Lancet Oncology · 2015 · 10.1016/s1470-2045(14)71173-8

  • Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer

    New England Journal of Medicine · 2013 · 10.1056/nejmoa1214886

  • Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

    Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.44.2806

  • Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL

    Journal of Clinical Oncology · 2009 · 10.1200/jco.2007.14.5466

  • Erlotinib in Previously Treated Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2005 · 10.1056/nejmoa050753

Current projects

    No projects listed.